BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 18086637)

  • 1. Combined hepatocellular carcinoma and cholangiocarcinoma: a case report and review of the literature.
    Zhou YM; Yang JM; Wang B; Xu F; Tong Y; Li DQ
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):656-9. PubMed ID: 18086637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
    Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
    Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
    Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Imaging and Clinically Relevant Features of Combined Hepatocellular Carcinoma and Cholangiocarcinoma with Hepatocellular Carcinoma.
    Huang X; Li Y; Long L
    Med Sci Monit; 2019 Nov; 25():8595-8601. PubMed ID: 31726461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 7. A successful resection and long-term survival of a patient with intrahepatic recurrences of combined hepatocellular-cholangiocarcinoma: report of a case.
    Eguchi H; Nagano H; Sakon M; Miyamoto A; Kondo M; Arai I; Morimoto O; Dono K; Umeshita K; Nakamori S; Wakasa K; Monden M
    Surg Today; 2002; 32(8):742-6. PubMed ID: 12181730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Yoon YI; Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee JW; Hong SM; Yu ES; Lee SG
    J Gastrointest Surg; 2016 Feb; 20(2):411-20. PubMed ID: 26628072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
    Na SK; Choi GH; Lee HC; Shin YM; An J; Lee D; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS
    PLoS One; 2018; 13(6):e0198138. PubMed ID: 29879137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases.
    Yano Y; Yamamoto J; Kosuge T; Sakamoto Y; Yamasaki S; Shimada K; Ojima H; Sakamoto M; Takayama T; Makuuchi M
    Jpn J Clin Oncol; 2003 Jun; 33(6):283-7. PubMed ID: 12913082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.
    Tang D; Nagano H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Monden M
    J Gastrointest Surg; 2006; 10(7):987-98. PubMed ID: 16843869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features.
    Fukukura Y; Taguchi J; Nakashima O; Wada Y; Kojiro M
    J Comput Assist Tomogr; 1997; 21(1):52-8. PubMed ID: 9022770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma.
    Kai K; Ide Y; Miyoshi A; Masuda M; Ide T; Kitahara K; Irie H; Nakajima J; Noshiro H; Tokunaga O
    Pathol Int; 2013 Aug; 63(8):419-21. PubMed ID: 23957918
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Yu XH; Xu LB; Zeng H; Zhang R; Wang J; Liu C
    Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):620-5. PubMed ID: 22146626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery for mixed hepatocellular and cholangiocellular carcinoma.
    Uenishi T; Hirohashi K; Shuto T; Yamamoto T; Kubo S; Tanaka H; Ikebe T; Kinoshita H
    Hepatogastroenterology; 2000; 47(33):832-4. PubMed ID: 10919041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
    Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K
    Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.
    Lee JH; Chung GE; Yu SJ; Hwang SY; Kim JS; Kim HY; Yoon JH; Lee HS; Yi NJ; Suh KS; Lee KU; Jang JJ; Kim YJ
    J Clin Gastroenterol; 2011 Jan; 45(1):69-75. PubMed ID: 20142755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence patterns of combined hepatocellular-cholangiocarcinoma on enhanced computed tomography.
    Shin CI; Lee JM; Kim SH; Choi JY; Lee JY; Han JK; Jo SY; Choi BI
    J Comput Assist Tomogr; 2007; 31(1):109-15. PubMed ID: 17259842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive imaging in the diagnosis of combined hepatocellular carcinoma and cholangiocarcinoma.
    Shen YT; Yue WW; Xu HX
    Abdom Radiol (NY); 2023 Jun; 48(6):2019-2037. PubMed ID: 36961531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
    Wang X; Wang W; Ma X; Lu X; Li S; Zeng M; Xu K; Yang C
    Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.